Related references
Note: Only part of the references are listed.Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis
Lieke Jakel et al.
ALZHEIMERS & DEMENTIA (2022)
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study
Andreas Charidimou et al.
LANCET NEUROLOGY (2022)
APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function
Monica Xiong et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Cortical Thickness and its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy
Arsenije Subotic et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways
Steven M. Greenberg et al.
NATURE REVIEWS NEUROLOGY (2020)
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Peter T. Nelson et al.
BRAIN (2019)
Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0
Andreas Charidimou et al.
INTERNATIONAL JOURNAL OF STROKE (2019)
Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment
Naira Goukasian et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2019)
The Revised National Alzheimer's Coordinating Center's Neuropathology Form-Available Data and New Analyses
Lilah M. Besser et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)
Atrophy patterns in cerebral amyloid angiopathy with and without cortical superficial siderosis
Joonho Kim et al.
NEUROLOGY (2018)
Ischemic brain injury in cerebral amyloid angiopathy
Yael D. Reijmer et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study
Panagiotis Fotiadis et al.
LANCET NEUROLOGY (2016)
Cerebral beta-Amyloid Angiopathy Is Associated with Earlier Dementia Onset in Alzheimer's Disease
Eric D. Vidoni et al.
NEURODEGENERATIVE DISEASES (2016)
White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy
Andreas Charidimou et al.
NEUROLOGY (2016)
Cerebral amyloid angiopathy with and without hemorrhage Evidence for different disease phenotypes
Andreas Charidimou et al.
NEUROLOGY (2015)
APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis
Kristiina Rannikmaee et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Outcome markers for clinical trials in cerebral amyloid angiopathy
Steven M. Greenberg et al.
LANCET NEUROLOGY (2014)
APOE ε4 Is Associated with Disproportionate Progressive Hippocampal Atrophy in AD
Emily N. Manning et al.
PLOS ONE (2014)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
Thomas J. Montine et al.
ACTA NEUROPATHOLOGICA (2012)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman et al.
ALZHEIMERS & DEMENTIA (2012)
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Joseph M. Castellano et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Brain Atrophy and Cerebral Small Vessel Disease A Prospective Follow-Up Study
Arani Nitkunan et al.
STROKE (2011)
Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease
A. Drzezga et al.
NEUROLOGY (2009)
Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain
B Fischl et al.
NEURON (2002)
Apolipoprotein E ε4 and the pattern of regional brain atrophy in Alzheimer's disease
M Hashimoto et al.
NEUROLOGY (2001)
Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria
KA Knudsen et al.
NEUROLOGY (2001)
Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4
JM Olichney et al.
ARCHIVES OF NEUROLOGY (2000)